INDO US BIO-TECH | NATH BIO GENES | INDO US BIO-TECH/ NATH BIO GENES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 9.7 | 434.7% | View Chart |
P/BV | x | 8.6 | 0.7 | 1,258.7% | View Chart |
Dividend Yield | % | 0.0 | 1.0 | - |
INDO US BIO-TECH NATH BIO GENES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
NATH BIO GENES Mar-23 |
INDO US BIO-TECH/ NATH BIO GENES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 262 | 47.9% | |
Low | Rs | 25 | 128 | 19.5% | |
Sales per share (Unadj.) | Rs | 61.6 | 158.6 | 38.8% | |
Earnings per share (Unadj.) | Rs | 7.2 | 18.4 | 39.2% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 20.0 | 40.2% | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.0% | |
Avg Dividend yield | % | 0 | 1.0 | 0.0% | |
Book value per share (Unadj.) | Rs | 54.3 | 301.7 | 18.0% | |
Shares outstanding (eoy) | m | 10.03 | 19.00 | 52.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 1.2 | 99.3% | |
Avg P/E ratio | x | 10.4 | 10.6 | 98.4% | |
P/CF ratio (eoy) | x | 9.4 | 9.7 | 95.9% | |
Price / Book Value ratio | x | 1.4 | 0.6 | 214.0% | |
Dividend payout | % | 0 | 10.9 | 0.0% | |
Avg Mkt Cap | Rs m | 754 | 3,707 | 20.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 233 | 5.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 3,014 | 20.5% | |
Other income | Rs m | 0 | 6 | 3.8% | |
Total revenues | Rs m | 618 | 3,019 | 20.5% | |
Gross profit | Rs m | 94 | 488 | 19.2% | |
Depreciation | Rs m | 8 | 30 | 27.4% | |
Interest | Rs m | 12 | 102 | 11.8% | |
Profit before tax | Rs m | 74 | 362 | 20.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 12 | 12.7% | |
Profit after tax | Rs m | 72 | 350 | 20.7% | |
Gross profit margin | % | 15.2 | 16.2 | 93.9% | |
Effective tax rate | % | 2.0 | 3.2 | 62.2% | |
Net profit margin | % | 11.7 | 11.6 | 100.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 5,208 | 11.5% | |
Current liabilities | Rs m | 123 | 2,165 | 5.7% | |
Net working cap to sales | % | 77.1 | 101.0 | 76.4% | |
Current ratio | x | 4.9 | 2.4 | 202.5% | |
Inventory Days | Days | 1 | 33 | 4.2% | |
Debtors Days | Days | 146,261,410 | 1,179 | 12,409,525.3% | |
Net fixed assets | Rs m | 90 | 2,720 | 3.3% | |
Share capital | Rs m | 100 | 190 | 52.8% | |
"Free" reserves | Rs m | 445 | 5,542 | 8.0% | |
Net worth | Rs m | 545 | 5,732 | 9.5% | |
Long term debt | Rs m | 17 | 4 | 423.1% | |
Total assets | Rs m | 689 | 7,928 | 8.7% | |
Interest coverage | x | 7.2 | 4.5 | 157.5% | |
Debt to equity ratio | x | 0 | 0 | 4,449.8% | |
Sales to assets ratio | x | 0.9 | 0.4 | 235.8% | |
Return on assets | % | 12.3 | 5.7 | 214.8% | |
Return on equity | % | 13.3 | 6.1 | 217.5% | |
Return on capital | % | 15.3 | 8.1 | 189.0% | |
Exports to sales | % | 0 | 2.7 | 0.0% | |
Imports to sales | % | 0 | 0.3 | 0.0% | |
Exports (fob) | Rs m | NA | 81 | 0.0% | |
Imports (cif) | Rs m | NA | 10 | 0.0% | |
Fx inflow | Rs m | 0 | 81 | 0.0% | |
Fx outflow | Rs m | 0 | 17 | 0.0% | |
Net fx | Rs m | 0 | 64 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 384 | 1.4% | |
From Investments | Rs m | -67 | -29 | 231.4% | |
From Financial Activity | Rs m | 63 | -17 | -377.0% | |
Net Cashflow | Rs m | 1 | 338 | 0.4% |
Indian Promoters | % | 70.2 | 45.6 | 153.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 4.6 | - | |
FIIs | % | 0.0 | 0.3 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 54.4 | 54.8% | |
Shareholders | 1,166 | 35,132 | 3.3% | ||
Pledged promoter(s) holding | % | 0.0 | 16.4 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | NATH BIO GENES |
---|---|---|
1-Day | 8.77% | 3.83% |
1-Month | 26.17% | 15.46% |
1-Year | 113.64% | 29.87% |
3-Year CAGR | 152.58% | -14.80% |
5-Year CAGR | 42.16% | -14.81% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the NATH BIO GENES share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of NATH BIO GENES the stake stands at 45.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of NATH BIO GENES.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
NATH BIO GENES paid Rs 2.0, and its dividend payout ratio stood at 10.9%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of NATH BIO GENES.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.